TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$10.610-0.170 (-1.577%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$10.780

Máximo

$10.780

Mínimo

$10.520

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

530.5M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.28M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $7.44Actual $10.610Máximo $11.82

Noticias Relacionadas

PR Newswire

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3...

Ver más
Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
PR Newswire

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first...

Ver más
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
PR Newswire

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of...

Ver más
Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress
PR Newswire

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2025 financial results and provide a business update after market close on...

Ver más
Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.